AU2002214325A1 - Process for producing carbapenem-type antibacterial - Google Patents
Process for producing carbapenem-type antibacterialInfo
- Publication number
- AU2002214325A1 AU2002214325A1 AU2002214325A AU1432502A AU2002214325A1 AU 2002214325 A1 AU2002214325 A1 AU 2002214325A1 AU 2002214325 A AU2002214325 A AU 2002214325A AU 1432502 A AU1432502 A AU 1432502A AU 2002214325 A1 AU2002214325 A1 AU 2002214325A1
- Authority
- AU
- Australia
- Prior art keywords
- type antibacterial
- carbapenem
- producing carbapenem
- salt
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/04—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A process for the preparation of a carbapenem-type antibacterial agent of formula (4) having a 1-alkylpyrrolidine structure or a salt thereof, a useful synthetic intermediate of formula (1) or a salt thereof, and a process for the preparation thereof: <CHEM> Äwherein R<1> represents a C1-C3 alkyl group, R<2> and R<3> each independently represents a hydrogen atom or the likeÜ.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-352178 | 2000-11-20 | ||
JP2000352178 | 2000-11-20 | ||
PCT/JP2001/010096 WO2002040482A1 (en) | 2000-11-20 | 2001-11-19 | Process for producing carbapenem-type antibacterial |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002214325A1 true AU2002214325A1 (en) | 2002-05-27 |
Family
ID=18825114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002214325A Abandoned AU2002214325A1 (en) | 2000-11-20 | 2001-11-19 | Process for producing carbapenem-type antibacterial |
Country Status (15)
Country | Link |
---|---|
US (2) | US7034150B2 (en) |
EP (1) | EP1338596B1 (en) |
KR (1) | KR100825243B1 (en) |
CN (1) | CN1247581C (en) |
AT (1) | ATE315568T1 (en) |
AU (1) | AU2002214325A1 (en) |
CA (1) | CA2429071A1 (en) |
CY (1) | CY1105598T1 (en) |
DE (1) | DE60116656T2 (en) |
DK (1) | DK1338596T3 (en) |
ES (1) | ES2256311T3 (en) |
HK (1) | HK1054745A1 (en) |
PT (1) | PT1338596E (en) |
TW (1) | TWI290925B (en) |
WO (1) | WO2002040482A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2602097A1 (en) * | 2005-03-22 | 2006-09-28 | Daiichi Sankyo Company, Limited | Process for producing carbapenem derivatives having 1-alkylpyrrolidine structure |
CN101328178B (en) * | 2007-06-15 | 2010-10-13 | 山东轩竹医药科技有限公司 | Penem derivates containing thiophen substituted sulfhydryl pyrrolidine |
CN101357919B (en) * | 2007-06-22 | 2011-06-15 | 山东轩竹医药科技有限公司 | Penem derivative containing sulfhydryl formamide benzenesulfonyl pyrrolidine |
CN101333219B (en) * | 2007-06-26 | 2010-10-13 | 山东轩竹医药科技有限公司 | Penem derivates with mercapto pyrrolidine formamide benzene alkyl heterocycle |
CN101367812B (en) * | 2007-06-28 | 2011-04-27 | 山东轩竹医药科技有限公司 | Sulfhydryl pyrrolidine formamido cyclopentene acid substituted penem derivant |
CN101343271B (en) * | 2007-07-13 | 2011-01-12 | 山东轩竹医药科技有限公司 | Penem derivant containing isoxazole alkyl ketone |
WO2011068543A1 (en) * | 2009-12-04 | 2011-06-09 | Becton, Dickinson And Company | Pen needle removal device for a drug delivery device |
CN102002069A (en) * | 2010-11-12 | 2011-04-06 | 上海巴迪生物医药科技有限公司 | Preparation method of dicyclic intermediate for synthesizing carbapenem side chains and application thereof |
EP2945929B1 (en) * | 2013-01-15 | 2020-01-22 | Merck Patent GmbH | Acylguanidines for the treatment of osteoarthritis |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4491541A (en) * | 1982-11-10 | 1985-01-01 | Farmitalia Carlo Erba | Peptides |
US4958029A (en) * | 1987-01-13 | 1990-09-18 | Banyu Pharmaceutical Co., Ltd. | Process for the production of isoindoline derivatives, novel intermediates and process for their production |
GB8809736D0 (en) * | 1988-04-25 | 1988-06-02 | Fujisawa Pharmaceutical Co | New cephem compounds & process for preparation thereof |
JP3091297B2 (en) | 1992-01-10 | 2000-09-25 | 住友製薬株式会社 | Pyrrolidine derivative and method for producing the same |
EP0882728B1 (en) | 1995-12-21 | 2002-09-04 | Sankyo Company Limited | 1-methylcarbapenem derivatives |
US5952338A (en) * | 1996-07-05 | 1999-09-14 | Takeda Chemical Industries, Ltd. | Agent for prophylaxis and treatment of disturbance of visual function |
JP2955276B2 (en) | 1997-06-19 | 1999-10-04 | 三共株式会社 | Antibacterial agent containing 1-methylcarbapenem derivative |
CA2294342C (en) * | 1997-07-09 | 2006-03-14 | Merck & Co., Inc. | Process for synthesizing carbapenem side chain intermediates |
US6063931A (en) * | 1997-07-09 | 2000-05-16 | Merck & Co., Inc. | Process for synthesizing carbapenem side chain intermediates |
WO2004078195A1 (en) * | 2003-03-07 | 2004-09-16 | Ajinomoto Co., Inc. | Agent for converting intestinal cell into insulin-producing cell and remedy for diabetes |
-
2001
- 2001-11-19 AT AT01982847T patent/ATE315568T1/en active
- 2001-11-19 CA CA002429071A patent/CA2429071A1/en not_active Abandoned
- 2001-11-19 DK DK01982847T patent/DK1338596T3/en active
- 2001-11-19 DE DE60116656T patent/DE60116656T2/en not_active Expired - Lifetime
- 2001-11-19 PT PT01982847T patent/PT1338596E/en unknown
- 2001-11-19 ES ES01982847T patent/ES2256311T3/en not_active Expired - Lifetime
- 2001-11-19 KR KR1020037006797A patent/KR100825243B1/en not_active IP Right Cessation
- 2001-11-19 TW TW090128583A patent/TWI290925B/en not_active IP Right Cessation
- 2001-11-19 CN CNB018220711A patent/CN1247581C/en not_active Expired - Fee Related
- 2001-11-19 EP EP01982847A patent/EP1338596B1/en not_active Expired - Lifetime
- 2001-11-19 WO PCT/JP2001/010096 patent/WO2002040482A1/en active IP Right Grant
- 2001-11-19 AU AU2002214325A patent/AU2002214325A1/en not_active Abandoned
-
2003
- 2003-05-14 US US10/438,649 patent/US7034150B2/en not_active Expired - Fee Related
- 2003-09-29 HK HK03107007A patent/HK1054745A1/en not_active IP Right Cessation
-
2005
- 2005-09-02 US US11/219,394 patent/US7091363B2/en not_active Expired - Fee Related
-
2006
- 2006-04-03 CY CY20061100467T patent/CY1105598T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1338596A4 (en) | 2004-08-04 |
US20060009508A1 (en) | 2006-01-12 |
US20030225055A1 (en) | 2003-12-04 |
CN1247581C (en) | 2006-03-29 |
EP1338596B1 (en) | 2006-01-11 |
KR20030097793A (en) | 2003-12-31 |
US7034150B2 (en) | 2006-04-25 |
EP1338596A1 (en) | 2003-08-27 |
HK1054745A1 (en) | 2003-12-12 |
ES2256311T3 (en) | 2006-07-16 |
KR100825243B1 (en) | 2008-04-25 |
DK1338596T3 (en) | 2006-04-18 |
DE60116656T2 (en) | 2006-09-21 |
CY1105598T1 (en) | 2010-07-28 |
US7091363B2 (en) | 2006-08-15 |
PT1338596E (en) | 2006-05-31 |
DE60116656D1 (en) | 2006-04-06 |
CN1486316A (en) | 2004-03-31 |
CA2429071A1 (en) | 2002-05-23 |
TWI290925B (en) | 2007-12-11 |
WO2002040482A1 (en) | 2002-05-23 |
ATE315568T1 (en) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY104627A (en) | A 1-pyridylimidazole derivative and its production and use. | |
CA2445306A1 (en) | Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
AU2001277753A1 (en) | Phosphonocephem compound | |
AU685116B2 (en) | Azolylamine derivative | |
EP1380564A4 (en) | Binaphtol derivative and process for producing the same | |
CA2231052A1 (en) | Benzoxazepine compounds, their production and use as lipid lowering agents | |
AU9281198A (en) | Benzofuran derivatives | |
AU2722095A (en) | Novel pyrrolocarbazoles | |
HU912649D0 (en) | New tricyclic compounds production threreof and anti-microbic preparatives | |
AU2002214325A1 (en) | Process for producing carbapenem-type antibacterial | |
EP1134219A4 (en) | Cycloalkyl-substituted aminomethylpyrrolidine derivatives | |
DE60223227D1 (en) | BenzoÄbÄthiophenderivate and process for their preparation | |
MY130488A (en) | Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols | |
HU9601701D0 (en) | Aromatic hydroxamic acid compounds, process for producing them and their use | |
IL162788A (en) | Process for preparing a tripeptide and salt thereof | |
AU2003248059A1 (en) | NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF | |
WO2002051822A3 (en) | Isothiazolecarboxamides as microbicides | |
EP1148059A4 (en) | Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof | |
AU4628399A (en) | Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them | |
AU2001225466A1 (en) | Pyrimidine derivatives having antitumor effect |